This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Saturday, March 25 • 11:00am - 11:45am
Examining Biosimilars within the IMID Treatment Landscape

Sign up or log in to save this to your schedule and see who's attending!

Immune-mediated inflammatory disease is one of the pivotal emerging fields for biosimilar development, with these agents offering potential reduced treatment costs, expanded market competition, and increased accessibility of medication.  Given the numerous potential biosimilars that could join the IMID treatment armamentarium, healthcare providers must be prepared to make informed clinical decisions regarding the safety and efficacy of these agents, based on available data. This session will focus on biosimilars and the complexities that surround their transition to clinical practice, navigating through the intricacies of biosimilar manufacturing, clinical profiles, divergence from reference products and generic formulations, and approval processes so that practitioners  may minimize errors in usage, discern the proper role for these emerging agents, and make the best informed clinical decisions for their IMID patients.

  • Describe the anticipated impact of biosimilars on expenditures, accessibility, and outcomes for patients with IMIDs
  • Highlight key differences among generic, reference biologic, and biosimilar agents with regard to manufacturing processes, immunogenicity, dose equivalence, interchangeability, and evidence base
  • Identify biosimilar regulatory processes for prescribing, such as risk  

avatar for Jonathan Kay, MD

Jonathan Kay, MD

Physician, Division of Rheumatology, UMass Memorial Medical Center Professor of Medicine, Director of Clinical Research, Rheumatology, University of Massachusetts Medical School
Dr. Kay received his medical degree from the University of California School of Medicine in San Francisco, California. He then completed an internship and residency at the Hospital of the University of Pennsylvania in Philadelphia and fellowships in rheumatology and immunology at The Brigham and Women’s Hospital and Harvard Medical School in Boston, Massachusetts. Dr. Kay is Professor of Medicine at the University of Massachusetts Medical... Read More →

Saturday March 25, 2017 11:00am - 11:45am